Pulmonary-Systemic Pressure Ratio Correlates with Morbidity in Cardiac Valve Surgery.


Journal

Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208

Informations de publication

Date de publication:
03 2019
Historique:
received: 30 04 2018
pubmed: 24 9 2018
medline: 8 6 2019
entrez: 24 9 2018
Statut: ppublish

Résumé

Pulmonary hypertension portends worse outcomes in cardiac valve surgery; however, isolated pulmonary artery pressures may not reflect patients' global cardiac function accurately. To better account for the interventricular relationship, the authors hypothesized that patients with greater pulmonary-systemic ratios (mean pulmonary arterial pressure)/(mean systemic arterial pressure) would correlate with worse outcomes after valve surgery. Retrospective cohort study. Single academic hospital. The study comprised 314 patients undergoing valve surgery with or without coronary artery bypass grafting (2004-2016) with Society of Thoracic Surgeons predicted risk scores and preoperative right heart catheterization. None. The pulmonary-systemic ratio was calculated as follows: mean pulmonary arterial pressure/mean systemic arterial pressure. Patients were stratified by pulmonary-systemic ratio quartile. Logistic regression was used to assess the risk-adjusted association between pulmonary-systemic ratio or mean pulmonary arterial pressure. Median pulmonary-systemic ratio was 0.33 (Q1-Q3: 0.23-0.65); median pulmonary arterial pressure was 29 (21-30) mmHg. Patients with the highest pulmonary-systemic ratio had the highest rates of morbidity and mortality (p < 0.0001). A high pulmonary-systemic ratio was associated with longer duration in the intensive care unit (p < 0.0001) and hospital (p < 0.0001). After risk-adjustment, pulmonary-systemic ratio and pulmonary arterial pressure were independently associated with morbidity and mortality, but the pulmonary-systemic ratio (odds ratio 23.88, p = 0.008, Wald 7.1) was more strongly associated than the pulmonary arterial pressure (odds ratio 1.035, p = 0.011, Wald 6.5). The pulmonary-systemic ratio is more strongly associated with risk-adjusted morbidity and mortality in valve surgery than pulmonary arterial pressure. By integrating ventricular interactions, this metric may better characterize the risk of valve surgery.

Identifiants

pubmed: 30243869
pii: S1053-0770(18)30826-7
doi: 10.1053/j.jvca.2018.08.190
pmc: PMC6379101
mid: NIHMS1507763
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

677-682

Subventions

Organisme : NHLBI NIH HHS
ID : T32 HL007849
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Références

Eur J Cardiothorac Surg. 2012 Apr;41(4):734-44; discussion 744-5
pubmed: 22378855
J Cardiothorac Vasc Anesth. 2018 Feb;32(1):32-40
pubmed: 29229262
Am J Cardiol. 1993 Nov 15;72(15):1179-82
pubmed: 8237810
Crit Care Med. 2013 Feb;41(2):464-71
pubmed: 23263580
Curr Cardiol Rev. 2010 Feb;6(1):1-14
pubmed: 21286273
J Cardiothorac Vasc Anesth. 2006 Jun;20(3):331-9
pubmed: 16750732
J Am Coll Cardiol. 2011 Feb 22;57(8):921-8
pubmed: 21329838
Can J Cardiol. 2001 Sep;17(9):940-59
pubmed: 11586386
J Thorac Cardiovasc Surg. 2011 Jun;141(6):1424-30
pubmed: 21596173
Eur Respir Rev. 2014 Dec;23(134):476-87
pubmed: 25445946
Eur Heart J. 2012 Oct;33(19):2451-96
pubmed: 22922415
Cardiovasc Res. 2017 Oct 1;113(12):1474-1485
pubmed: 28957537
J Thorac Cardiovasc Surg. 2013 Sep;146(3):631-7
pubmed: 22982034
Echocardiography. 2014 Jul;31(6):699-707
pubmed: 24372843
J Thorac Cardiovasc Surg. 2011 Dec;142(6):1439-52
pubmed: 21962906
J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S55-66
pubmed: 19555859
Clin Chest Med. 2007 Mar;28(1):233-41, x
pubmed: 17338938
J Thorac Cardiovasc Surg. 2014 Jan;147(1):483-9
pubmed: 24075467

Auteurs

Sarah A Schubert (SA)

Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, VA. Electronic address: ss9kw@virginia.edu.

J Hunter Mehaffey (JH)

Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, VA.

Alexander Booth (A)

University of Virginia School of Medicine, Charlottesville, VA.

Leora T Yarboro (LT)

Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, VA.

John A Kern (JA)

Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, VA.

Jamie L W Kennedy (JLW)

Division of Cardiovascular Medicine, Department of Medicine, University of Virginia, Charlottesville, VA.

Gorav Ailawadi (G)

Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, VA.

Sula Mazimba (S)

Division of Cardiovascular Medicine, Department of Medicine, University of Virginia, Charlottesville, VA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH